相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Matrix metalloproteinase (MMP)-2 gene polymorphisms affect circulating MMP-2 levels in patients with migraine with aura
Flavia M. Goncalves et al.
GENE (2013)
Matrix Metalloproteinase (MMP)-2 Genetic Variants Modify the Circulating MMP-2 Levels in End-Stage Kidney Disease
Bernardo P. Marson et al.
AMERICAN JOURNAL OF NEPHROLOGY (2012)
Association between matrix metalloproteinase (MMP)-2 polymorphisms and MMP-2 levels in hypertensive disorders of pregnancy
Ana C. T. Palei et al.
EXPERIMENTAL AND MOLECULAR PATHOLOGY (2012)
Matrix metalloproteinase-9 genetic variations affect MMP-9 levels in obese children
V. A. Belo et al.
INTERNATIONAL JOURNAL OF OBESITY (2012)
Common matrix metalloproteinase 2 gene haplotypes may modulate left ventricular remodelling in hypertensive patients
R. Lacchini et al.
JOURNAL OF HUMAN HYPERTENSION (2012)
Consistent Alterations of Circulating Matrix Metalloproteinases Levels in Untreated Hypertensives and in Spontaneously Hypertensive Rats: A Relevant Pharmacological Target
Vanessa Fontana et al.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2011)
Metalloproteinases in metabolic syndrome
Gabriela Berg et al.
CLINICA CHIMICA ACTA (2011)
A common matrix metalloproteinase (MMP)-2 polymorphism affects plasma MMP-2 levels in subjects environmentally exposed to mercury
Anna L. B. Jacob-Ferreira et al.
SCIENCE OF THE TOTAL ENVIRONMENT (2011)
Obesity-Related Hypertension: Epidemiology, Pathophysiology, and Clinical Management
Theodore A. Kotchen
AMERICAN JOURNAL OF HYPERTENSION (2010)
Variants of the Matrix Metalloproteinase-2 but not the Matrix Metalloproteinase-9 genes significantly influence functional outcome after stroke
Helena Manso et al.
BMC MEDICAL GENETICS (2010)
Matrix Metalloproteinase Inhibition Improves Cardiac Dysfunction and Remodeling in 2-Kidney, 1-Clip Hypertension
Elen Rizzi et al.
JOURNAL OF CARDIAC FAILURE (2010)
Modification of vascular and inflammation biomarkers after OGTT in overweight healthy and diabetic subjects
Giuseppe Derosa et al.
MICROVASCULAR RESEARCH (2010)
Matrix metalloproteinase (MMP-9 and MMP-2) gene polymorphisms influence allograft survival in renal transplant recipients
Ranjana Singh et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2010)
Gelatinase B (MMP-9) deficiency does not affect murine adipose tissue development
Matthias Van Hul et al.
THROMBOSIS AND HAEMOSTASIS (2010)
Metalloproteases 2 and 9, Lp-PLA(2) and Lipoprotein Profile in Coronary Patients
Maria Luz Muzzio et al.
ARCHIVES OF MEDICAL RESEARCH (2009)
Assessment of matrix metalloproteinase (MMP)-2, MMP-8, MMP-9, and their inhibitors, the tissue inhibitors of metalloproteinase (TIMP)-1 and TIMP-2 in obese children and adolescents
Vanessa A. Belo et al.
CLINICAL BIOCHEMISTRY (2009)
Evaluation of metalloproteinase 2 and 9 levels and their inhibitors in combined dyslipidemia
Giuseppe Derosa et al.
CLINICAL AND INVESTIGATIVE MEDICINE (2009)
Metalloproteinase inhibition ameliorates hypertension and prevents vascular dysfunction and remodeling in renovascular hypertensive rats
Michele A. Castro et al.
ATHEROSCLEROSIS (2008)
Angiogenesis and obesity
H. Roger Lijnen
CARDIOVASCULAR RESEARCH (2008)
Matrix metalloproteinase-2 and-9 levels in obese patients
G. Derosa et al.
ENDOTHELIUM-JOURNAL OF ENDOTHELIAL CELL RESEARCH (2008)
A functional role of gelatinase A in the development of nutritionally induced obesity in mice
M. Van Hul et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2008)
Matrix metallopeptidase 2 gene polymorphism is associated with obesity in Korean population
Dong Hee Han et al.
KOREAN JOURNAL OF PHYSIOLOGY & PHARMACOLOGY (2008)
Increased plasma activity of metalloproteinase 2 in women with metabolic syndrome
Veronica Miksztowicz et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2008)
Metalloproteinases in diabetics and nondiabetics during acute coronary syndromes and after 3 months
Giuseppe Derosa et al.
ENDOTHELIUM-JOURNAL OF ENDOTHELIAL CELL RESEARCH (2007)
Metalloproteinase-2 and-9 in diabetic and nondiabetic subjects during acute coronary syndromes
Giuseppe Derosa et al.
ENDOTHELIUM-JOURNAL OF ENDOTHELIAL CELL RESEARCH (2007)
Rapid separation of serum does not avoid artificially higher matrix metalloproteinase (MMP)-9 levels in serum versus plasma
Raquel F. Gerlach et al.
CLINICAL BIOCHEMISTRY (2007)
Mechanisms linking obesity with cardiovascular disease
Luc F. Van Gaal et al.
NATURE (2006)
Matrix metalloproteinases/tissue inhibitors of metalloproteinases - Relationship between changes in proteolytic determinants of matrix composition and structural, functional, and clinical manifestations of hypertensive heart disease
SH Ahmed et al.
CIRCULATION (2006)
Matrix metalloproteinase-2,-9, and tissue inhibitor of metalloproteinase-1 in patients with hypertension
Giuseppe Derosa et al.
ENDOTHELIUM-JOURNAL OF ENDOTHELIAL CELL RESEARCH (2006)
Genetic polymorphism of matrix metalloproteinase (MMP)-9 does not affect plasma MMP-9 activity in healthy subjects
C Demacq et al.
CLINICA CHIMICA ACTA (2006)
Structure and function of matrix metalloproteinases and TIMPs
H Nagase et al.
CARDIOVASCULAR RESEARCH (2006)
Lercanidipine reduces matrix metalloproteinase-9 activity in patients with hypertension
MLL Martinez et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2006)
Methodological issues affecting the determination of plasma matrix metalloproteinase (MMP)-2 and MMP-9 activities
CD Souza-Tarla et al.
CLINICAL BIOCHEMISTRY (2005)
Overweight in children and adolescents - Pathophysiology, consequences, prevention, and treatment
SR Daniels et al.
CIRCULATION (2005)
Homeostasis model assessment is more reliable than the fasting glucose/insulin ratio and quantitative insulin sensitivity check index for assessing insulin resistance among obese children and adolescents
M Keskin et al.
PEDIATRICS (2005)
Matrix metalloproteinase-9 (MMP-9), MMP-2, and serum elastase activity are associated with systolic hypertension and arterial stiffness
Yasmin et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2005)
The effect of Ca2+ channel antagonists on plasma concentrations of matrix metalloproteinase-2 and-9 in essential hypertension
A Zervoudaki et al.
AMERICAN JOURNAL OF HYPERTENSION (2004)
Obesity and the metabolic syndrome in children and adolescents
R Weiss et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Functional haplotypes in the promoter of matrix metalloproteinase-2 predict risk of the occurrence and metastasis of esophageal cancer
CY Yu et al.
CANCER RESEARCH (2004)
Prevalence of a metabolic syndrome phenotype in adolescents - Findings from the Third National Health and Nutrition Examination Survey, 1988-1994
S Cook et al.
ARCHIVES OF PEDIATRICS & ADOLESCENT MEDICINE (2003)
Economic burden of obesity in youths aged 6 to 17 years: 1979-1999
GJ Wang et al.
PEDIATRICS (2002)
Matrix metalloproteinase inhibition impairs adipose tissue development in mice
HR Lijnen et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2002)
A new statistical method for haplotype reconstruction from population data
M Stephens et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2001)
Identification of novel, functional genetic variants in the human matrix metalloproteinase-2 gene - Role of Sp1 in allele-specific transcriptional regulation
SJ Price et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
分享论文
